Therapeutic monoclonal antibodies: scFv patents as a marker of a new class of potential biopharmaceuticals
Monoclonal antibodies represent the fastest growing class of biopharmaceutical products and have a host of applications in medical research, diagnosis, therapy, and basic science. The production of recombinant monoclonal antibodies has revolutionized the generation of immunoglobulins, and their use...
Saved in:
Main Authors: | Manuela Berto Pucca (Author), Thaís Barboza Bertolini (Author), José Elpidio Barbosa (Author), Simone Vasconcelos Ribeiro Galina (Author), Geciane Silveira Porto (Author) |
---|---|
Format: | Book |
Published: |
Universidade de São Paulo,
2011-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
"Stapling" scFv for multispecific biotherapeutics of superior properties
by: Lauren E. Boucher, et al.
Published: (2023) -
Exploring molecular determinants and pharmacokinetic properties of IgG1-scFv bispecific antibodies
by: Kristina M.J. Aertker, et al.
Published: (2024) -
Chaperone-Assisted Soluble Expression of a Humanized Anti-EGFR ScFv Antibody in E. Coli
by: Kamal Veisi, et al.
Published: (2015) -
The improvement of anti-HER2 scFv soluble expression in Escherichia coli
by: Farzaneh Farshdari, et al.
Published: (2020) -
Implementation of a Design of Experiments to Improve Periplasmic Yield of Functional ScFv Antibodies in a Phage Display Platform
by: Marjan Abri Aghdam, et al.
Published: (2022)